Farum, Denmark

Knud Aunstrup

This inventor holds 3 USPTO granted patents. Top assignee: Novo Industri A/s. Active years: 1978-1986.


% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • Farum, DK (1978 - 1981)
  • Fredensborg, DK (1986)

Company Filing History:


Years Active: 1978-1986

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Knud Aunstrup: Innovator in Enzyme Technology

Introduction

Knud Aunstrup is a notable inventor based in Farum, Denmark. He has made significant contributions to the field of enzyme technology, holding a total of 3 patents. His work focuses on developing novel enzymes with improved stability and reduced allergenicity, which have important applications in various industries.

Latest Patents

Aunstrup's latest patents include the development of an alpha-acetolactate decarboxylase enzyme. This novel enzyme product boasts improved stability and is produced in high levels by cultivating specific Bacillus strains. Another significant patent involves a protease product with reduced allergenicity, suitable for use in washing compositions. This product is prepared by cultivating mutated strains of Bacillus licheniformis, which block the synthesis of other proteases, thus enhancing its safety and effectiveness.

Career Highlights

Knud Aunstrup is associated with Novo Industri A/S, a company known for its innovative approaches in biotechnology. His work has contributed to advancements in enzyme applications, making a positive impact on both industrial processes and consumer products.

Collaborations

Aunstrup has collaborated with notable colleagues, including Peter Tang and Grethe C Nielsen. These partnerships have fostered a collaborative environment that enhances research and development efforts in enzyme technology.

Conclusion

Knud Aunstrup's contributions to enzyme technology through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence advancements in biotechnology and related industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…